[Sponsored] A Data-Driven Guide to Patient Access Success highlights how focusing on data accuracy and relevance can enhance healthcare practice performance. The post A Guide to Boosting Healthcare Practice Performance appeared first on MedCity News.
Teladoc Health’s acquisition of Catapult Health will add “another channel” to funnel patients into Teladoc’s chronic care programs, according to one healthcare expert. The post Why Teladoc Health is Acquiring Catapult Health for $65M appeared first on MedCity News.
Currently available therapies for Hunter syndrome don’t cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denali’s Data in Rare Enzyme Deficiency Keep It on Pace…
If the guidelines for data sharing are not adhered to by providers, then all the work that has gone into revising this regulation will have been for nothing. But the road to compliance doesn’t have to be overwhelming. Here are three essential steps for healthcare leaders in navigating the soon-to-be Part 2 landscape. The post…
[Sponsored] In a webinar sponsored by Jotform, scheduled for Wednesday March 5 at 1pm ET, panelists will discuss how health tech vendors and healthcare practices approach data automation and how they can collaborate effectively. The post Using Automation to Streamline Healthcare Practice Workflows and Maximize Staff Effectiveness appeared first on MedCity News.
Regulators will have their work cut out for them under a new administration that has expressed an anti-regulatory preference. Republicans next year will control the White House, Senate and House. What will it all mean for pharmacy leaders? The post Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025? appeared…
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley. The post “Precision Med Has Evolved as Badly As I Expected” And OtherTakeaways From Former FDA Commissioner At PMWC appeared first…
Novo Nordisk’s monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity. The post Oral Metabolic…
Little Otter’s $9.5 million fundraise included participation from Pivotal Ventures, Torch Capital, Springbank, CRV, Next Legacy, G9, Gratitude Railroad and Carrie Walton Penner’s Fiore Ventures. The company has raised more than $36 million to date. The post Little Otter Raises $9.5M for Family Mental Health appeared first on MedCity News.
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures. The post Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry appeared first on MedCity News.